[1
]
From the Duke University Medical Center (K.M.S., O.C., E.W.S.C.) and RTI International
(D.W.), Durham, and Rho Federal Systems Division, Chapel Hill (L.K.-E., A.P., B.E.,
S.C.) - all in North Carolina; National Institute of Allergy and Infectious Diseases,
Bethesda, MD (E.A.G., B.W., L.M.G., J.S.G.); Colorado Blood Cancer Institute, Denver
(P.A.M., R.A.N.); University of Texas McGovern Medical School (M.D.M.) and M.D. Anderson
Cancer Center (C.H.) - both in Houston; Vanderbilt University, Nashville (L.J.C.,
K.P.); University of Michigan, Ann Arbor (D.K., J.R.S.); Case Western Reserve University
and University Hospitals, Cleveland (R.J.F.); University of Alabama, Birmingham (S.M.);
Boston University, Boston (R.W.S.); University of Virginia, Charlottesville (K.B.);
University of Washington (M.H.W., D.E.F.) and the Fred Hutchinson Cancer Research
Center (G.E.G., S.H.) - both in Seattle; University of California, Los Angeles, Los
Angeles (J.G., S.K., D.E.F.); City of Hope National Medical Center, Duarte, CA (S.F.);
Medical University of South Carolina, Charleston (R.M.S.); Mayo Clinic, Scottsdale,
AZ (L.G.); University of Calgary, Calgary, AB, Canada (J.S., S.L.); Washington University,
St. Louis (R.B.); Medical College of Wisconsin, Milwaukee (M.E.C., C.K.-T.); Ottawa
Hospital Research Institute, Ottawa (C.B.); University of Pittsburgh, Pittsburgh (T.M.,
R.T.D.); and University of Toledo Medical Center, Toledo, OH (M.B.K.).